Publications
Download CSV
Download XLSX
Download TXT
Tables
2024 (300)
2023 (883)
2022 (829)
2021 (891)
2020 (640)
2019 (727)
2018 (651)
2017 (681)
2016 (664)
2015 (429)
2014 (376)
2013 (319)
2012 (245)
2011 (163)
2010 (139)
All (7937)
Infrastructure Units
Infrastructure Units list
Infrastructure Units table
Researchers
Subset
Documentation
About
Contact
Software
Login
Leuk. Lymphoma
JSON
ISSN
1029-2403
ISSN-L
1026-8022
IUID
2ab4d1a2402e43e69a9b0e28d33ecc86
Modified
2020-11-27T13:14:00.694Z
Created
2017-05-09T09:12:52.333Z
Year 2021
PubMed
DOI
Crossref
Limited benefit in patients with MDS receiving venetoclax and azacitidine as a bridge to allogeneic stem cell transplantation.
Jädersten M, Boriskina K, Lindholm C, ..., Mielke S,
Tobiasson M
Leuk. Lymphoma
-
(-) 1-4 [2021-11-15; online 2021-11-15]
Clinical Genomics Uppsala [Collaborative]
PubMed
DOI
Crossref
Targeted genomic investigations in a population-based cohort of mantle cell lymphoma reveal novel clinically relevant targets.
Rodrigues JM
, Porwit A, Hassan M,
Ek S
, Jerkeman M
Leuk. Lymphoma
62
(11) 2637-2647 [2021-11-00; online 2021-06-03]
Clinical Genomics Lund [Service]
PubMed
DOI
Crossref
Proteomic analysis in diffuse large B-cell lymphoma identifies dysregulated tumor microenvironment proteins in non-GCB/ABC subtype patients.
Bram Ednersson S, Stern M, Fagman H, ..., Thorsell A, Andersson PO
Leuk. Lymphoma
62
(10) 2360-2373 [2021-10-00; online 2021-06-11]
Glycoproteomics and MS Proteomics [Collaborative]
Year 2020
PubMed
DOI
Crossref
Overexpression of chromatin remodeling and tyrosine kinase genes in iAMP21-positive acute lymphoblastic leukemia.
Ivanov Öfverholm I
,
Zachariadis V
,
Taylan F
, ...,
Nordlund J
, Barbany G
Leuk. Lymphoma
61
(3) 604-613 [2020-03-00; online 2019-10-22]
Bioinformatics Support for Computational Resources [Service]
NGI Uppsala (SNP&SEQ Technology Platform) [Collaborative]
National Genomics Infrastructure [Collaborative]
Year 2019
PubMed
DOI
Crossref
Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in TET2, DNMT3 and CUX1 - azacitidine induces only lymphoma remission.
Tobiasson M
, Pandzic T,
Cavelier L
, Sander B, Wahlin BE
Leuk. Lymphoma
60
(13) 3316-3319 [2019-12-00; online 2019-06-17]
Clinical Genomics Uppsala [Collaborative]
Year 2016
PubMed
DOI
Crossref
Detailed gene dose analysis reveals recurrent focal gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia.
Ivanov Öfverholm I, Tran AN, Olsson L, ..., Nordgren A, Barbany G
Leuk. Lymphoma
57
(9) 2161-2170 [2016-09-00; online 2016-04-20]
Clinical Genomics Stockholm [Service]
PubMed
DOI
Crossref
Serum nuclear magnetic resonance-based metabolomics and outcome in diffuse large B-cell lymphoma patients - a pilot study.
Stenson M, Pedersen A, Hasselblom S, ..., Pinto R, Andersson PO
Leuk. Lymphoma
57
(8) 1814-1822 [2016-08-00; online 2016-02-17]
Bioinformatics Support and Infrastructure [Collaborative]
Bioinformatics Support, Infrastructure and Training [Collaborative]
Swedish NMR Centre (SNC) [Collaborative]
SciLifeLab Data Centre
Publications
9.5.1